Skip to Content

Staar Surgical Co STAA

Morningstar Rating
$42.50 −0.64 (1.48%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

STAA is trading at a 337% premium.
Price
$42.69
Fair Value
$38.26
Uncertainty
High
1-Star Price
$32.25
5-Star Price
$51.72
Economic Moat
Mwxdm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if STAA is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$43.14
Day Range
$41.3343.33
52-Week Range
$26.6658.35
Bid/Ask
$42.29 / $42.70
Market Cap
$2.09 Bil
Volume/Avg
503,953 / 572,317

Key Statistics

Price/Earnings (Normalized)
48.14
Price/Sales
6.42
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
0.07%

Company Profile

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Growth
Total Number of Employees
1,115

Comparables

Valuation

Metric
STAA
RXST
SGHT
Price/Earnings (Normalized)
48.14
Price/Book Value
5.2810.603.45
Price/Sales
6.4216.544.57
Price/Cash Flow
40.99
Price/Earnings
STAA
RXST
SGHT

Financial Strength

Metric
STAA
RXST
SGHT
Quick Ratio
4.998.0212.22
Current Ratio
5.849.2013.01
Interest Coverage
−27.34−9.24
Quick Ratio
STAA
RXST
SGHT

Profitability

Metric
STAA
RXST
SGHT
Return on Assets (Normalized)
7.37%−13.53%−23.22%
Return on Equity (Normalized)
9.21%−16.23%−32.00%
Return on Invested Capital (Normalized)
7.12%−17.05%−22.54%
Return on Assets
STAA
RXST
SGHT
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
ChmctkcrhGjvg$161.7 Bil
Becton Dickinson & Co
BDX
XlxnfjkTdnvsry$66.7 Bil
Alcon Inc
ALC
CyrsdcsgMbtkk$44.4 Bil
ResMed Inc
RMD
TvlbbmcscCgryhtm$29.8 Bil
Coloplast A/S ADR
CLPBY
BklpgpxpsDhwzs$28.2 Bil
West Pharmaceutical Services Inc
WST
CgcmwgmllhXcgs$23.3 Bil
Hologic Inc
HOLX
YmlrbgkrTxvrbf$18.2 Bil
The Cooper Companies Inc
COO
WklxnwcpLmpshq$18.1 Bil
Baxter International Inc
BAX
BrqhplbngYfbxl$18.0 Bil
Teleflex Inc
TFX
KpvmyJsnd$10.4 Bil

Sponsor Center